Balance Sheet Data

Spero Therapeutics, Inc. (SPRO)

$1.64

+0.14 (+9.33%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 115.4482.05126.91146.40109.111,328.192,583.635,025.729,776.1319,016.70
Total Cash (%)
Account Receivables 1.308.556.182.641.0855.91108.76211.56411.54800.53
Account Receivables (%)
Inventories -8.78-13.37-12.24-38.60-102.73-199.83-388.70-756.11-1,470.81-2,861.04
Inventories (%)
Accounts Payable 3.604.151.151.100.6237.4272.78141.58275.41535.73
Accounts Payable (%)
Capital Expenditure -2.44-0.31-0.160.04-8.44-16.42-31.94-62.14-120.87-235.12
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.